Yahoo Web Search

Search results

1. www.pulsebiosciences.comPulse Biosciences

   www.pulsebiosciences.com

   • Cached

   Welcome. Pulse Biosciences pioneers in the research, design and production of our patented Nanosecond Pulsed Field Ablation ™ (nsPFA ™) technology for use in high impact areas of healthcare. We are currently focused on applying our proprietary CellFX ® nsPFA ™ technology within cardiology.

   • Investors

     Pulse Biosciences is a novel bioelectric medicine company...

   • Code of Business Conduct and Ethics

     Pulse Biosciences, Inc. (“Pulse”) is committed to...

   • Press Releases

     Pulse Biosciences Schedules First Quarter 2024 Financial...

2. Videos

   • 

     5:14

     youtube.com

     Pulse Biosciences explains the unique nature of our pulses

     28 Dec 2015

     2.5K views

   • 

     linkedin.com

     Pulse Biosciences, Inc. | LinkedIn

     28 Apr 2017

   • 

     1:32

     youtube.com

     How Our Technology Works

     31 Mar 2020

     5.2K views

   View all

3. finance.yahoo.com › news › pulse-biosciencesPulse Biosciences Announces First-in-Human Procedures with ...

   finance.yahoo.com › news › pulse-biosciences

   • Cached

   Dec 20, 2023 · HAYWARD, Calif., December 20, 2023--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation...

4. investors.pulsebiosciences.com › news-releasesPulse Biosciences Announces First-in-Human Procedures with ...

   investors.pulsebiosciences.com › news-releases

   • Cached

   HAYWARD, Calif. -- (BUSINESS WIRE)--Dec. 20, 2023-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced the completion of the first five procedures in its first-in-human ...

5. Top stories

   • 

     YAHOO!Finance

     President & CEO of Pulse Biosciences Burke Barrett Buys More Stock

     1 week ago

   • 

     Yahoo Finance

     Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000

     2 weeks ago

   • bovnews

     Why Pulse Biosciences Inc (NASDAQ:PLSE) Stock went up 90.73% in Last Year?

     Stephens raised the price target for the Pulse Biosciences Inc (NASDAQ:PLSE) stock to “an Overweight”. The rating was released on July 27, 2021, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy,

     1 week ago

   View all

6. investors.pulsebiosciences.com › news-releasesPulse Biosciences Reports Business Updates and Fourth Quarter ...

   investors.pulsebiosciences.com › news-releases

   • Cached

   Mar 28, 2024 · Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue.

7. finance.yahoo.com › news › pulse-biosciencesPulse Biosciences Announces First U.S. Procedure with the ...

   finance.yahoo.com › news › pulse-biosciences

   • Cached

   May 9, 2024 · HAYWARD, Calif., May 09, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today...

8. www.linkedin.com › company › pulse-biosciences-incPulse Biosciences, Inc. | LinkedIn

   www.linkedin.com › company › pulse-biosciences-inc

   Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and...

9. People also ask

   What is Pulse Biosciences?

   • Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients.

   Pulse Biosciences Announces First-in-Human Procedures with its Novel …

   finance.yahoo.com/news/pulse-biosciences-announces-first-human-130000372.html

   See all results for this question

   Is Pulse Biosciences a trademark?

   • Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

   Pulse Biosciences Announces First-in-Human Procedures with its Novel …

   finance.yahoo.com/news/pulse-biosciences-announces-first-human-130000372.html

   See all results for this question

   Will Pulse Biosciences inform stakeholders if results differ?

   • Pulse Biosciences will inform stakeholders promptly if results differ materially from the stated expectations addressing safety and efficacy. The observations to date have been positive but the broad set of risks associated with cardiac surgery remain.

   Pulse Biosciences Announces First-in-Human Procedures with its Novel …

   finance.yahoo.com/news/pulse-biosciences-announces-first-human-130000372.html

   See all results for this question

   Does Pulse Biosciences have a nspfa percutaneous system?

   • This proprietary system is designed for non-cardiac applications. "Treating our first patient under our newly FDA-cleared nsPFA percutaneous system is a fundamental and opportune milestone for Pulse Biosciences," said Mitch Levinson, Chief Strategy Officer of Pulse Biosciences.

   Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA …

   finance.yahoo.com/news/pulse-biosciences-announces-first-u-120000047.html

   See all results for this question

10. investors.pulsebiosciences.com › news-releasesPulse Biosciences’ First Study in a Surgical Application of ...

    investors.pulsebiosciences.com › news-releases

    • Cached

    Sep 27, 2023 · Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients.